Further investigation of citalopram on alcohol consumption in heavy drinkers: responsiveness possibly linked to the DRD2 A2/A2 genotype.
Eriksson
M
M
Institute of Clinical Neuroscience, Department of Psychiatry and Neurochemistry, Göteborg University, Sahlgren University Hospital/Mölndal, SE-431 80 Mölndal, Sweden.
Berggren
U
U
Blennow
K
K
Fahlke
C
C
Balldin
J
J
D000328:Adult; D000368:Aged; D000428:Alcohol Drinking / Q000188:drug therapy* / Q000235:genetics* / Q000378:metabolism; D000483:Alleles; D000704:Analysis of Variance; D015283:Citalopram / Q000494:pharmacology / Q000627:therapeutic use*; D004311:Double-Blind Method; D005500:Follow-Up Studies; D005838:Genotype; D006801:Humans; D008099:Liver / Q000187:drug effects / Q000201:enzymology; D008111:Liver Function Tests; D008297:Male; D008875:Middle Aged; D008995:Monoamine Oxidase / Q000378:metabolism; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D017367:Selective Serotonin Reuptake Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D015283:Citalopram; D008995:Monoamine Oxidase; D017448:Receptors, Dopamine D2; D017367:Selective Serotonin Reuptake Inhibitors